Evidence map›Paper›PMID 40805810›Full record

ArticleHealthcare (Basel, Switzerland)2025

Group-Based Trajectory Model to Assess Adjuvant Endocrine Therapy Adherence Pattern in HR-Positive Breast Cancer: Results from Rio Grande Valley Patients.

Bilqees Fatima, Phillip Shayne Pruneda, Parasto Mousavi, Rheena Sheriff, Ronnie Ozuna, Meghana V Trivedi, Susan Abughosh

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Healthcare (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Bilqees FatimaDepartment of Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, Houston, TX 77204, USA.
Phillip Shayne PrunedaDepartment of Pharmacy Practice and Translational Research, College of Pharmacy, University of Houston, Houston, TX 77204, USA.
Parasto MousaviDepartment of Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, Houston, TX 77204, USA.
Rheena SheriffDoctors Hospital at Renaissance, Edinburg, TX 78539, USA.
Ronnie OzunaRio Grande Valley, Doctors Hospital at Renaissance, College of Pharmacy, University of Houston, Houston, TX 77204, USA.
Meghana V TrivediDepartment of Pharmacy Practice and Translational Research, College of Pharmacy, University of Houston, Houston, TX 77204, USA.ORCID 0000-0002-0585-5580
Susan AbughoshDepartment of Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, Houston, TX 77204, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adherencebreast cancergroup-based trajectory modeloral endocrine therapy

Identifiers

PMID40805810
PMCPMC12345857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.